Iterum Therapeutics
Dublin, US · Founded 2015 · Ireland corporation · 5 known investors
Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens. The company's lead product, sulopenem (ORLYNVAH), has been approved by the FDA for treating uncomplicated urinary tract infections in adult women.
Founders & leadership
Iterum Therapeutics was founded in 2015 by Michael W. Dunne and Corey N. Fishman.
MW
Michael W. DunneCo-founder
CN
Corey N. FishmanCo-founder
JM
Judith M. MatthewsExecutive
JS
Jeff SchaffnitExecutive
Board
BK
Brenton K. AhrensBoard director
RM
Ronald M. HuntBoard director
MC
Mark ChinBoard director
RH
Robert HopfnerBoard director
SM
Shahzad MalikBoard director
PJ
DI
David I. KellyBoard director
PR
Paul R. EdickBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$131.4M disclosed across 4 rounds · 2015–2020
▶$2.8MraisedJul 2020 · 8 investors · PharmaceuticalsRule 506(b)
▶$2.8MraisedJul 2020 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shahzad MalikDirector
- David KellyDirector
- Judith M. MatthewsExecutive Officer
- Michael DunneExecutive Officer
- Mark ChinDirector
- Louise BarrettExecutive Officer
- Brenton K. AhrensDirector
- Patrick J. HeronDirector
- Corey N. FishmanExecutive Officer, Director
- Ronald M. HuntDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Sales commissions
- $350K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jul 2020
- Incorporated
- Corporation, Ireland, 2015
- Federal exemptions
- 06b
▶$2.8MraisedJun 2020 · 8 investors · PharmaceuticalsRule 506(b)
▶$2.8MraisedJun 2020 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael DunneExecutive Officer
- Patrick J. HeronDirector
- Judith M. MatthewsExecutive Officer
- Brenton K. AhrensDirector
- Mark ChinDirector
- Ronald M. HuntDirector
- Shahzad MalikDirector
- Corey N. FishmanExecutive Officer, Director
- David KellyDirector
- Louise BarrettExecutive Officer
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Sales commissions
- $350K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jun 2020
- Incorporated
- Corporation, Ireland, 2015
- Federal exemptions
- 06b
▶$78.1MraisedMar 2018 · 17 investors · BiotechnologyRule 506(b)
▶$78.1MraisedMar 2018 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brenton K. AhrensDirector
- Michael W. DunneExecutive Officer, Promoter
- Ronald M. HuntDirector
- Mark ChinDirector
- Corey N. FishmanExecutive Officer, Director, Promoter
- Robert HopfnerDirector
- Judith M. MatthewsExecutive Officer, Promoter
- Shahzad MalikDirector
- Jeff SchaffnitExecutive Officer
- Patrick J. HeronDirector
- David I. KellyDirector
- Paul R. EdickDirector
- James I. HealyDirector
- Offering amount
- $78.1M
- Amount sold
- $78.1M
- First sale
- May 2017
- Incorporated
- Other, Ireland, 2015
- Federal exemptions
- 06b
▶$47.6MraisedDec 2016 · 13 investors · BiotechnologyRule 506(b)
▶$47.6MraisedDec 2016 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Corey N. FishmanExecutive Officer, Director, Promoter
- Patrick J. HeronDirector
- Judith M. MatthewsExecutive Officer, Promoter
- Ronald M. HuntDirector
- James I. HealyDirector
- Brenton K. AhrensDirector
- Michael W. DunneExecutive Officer, Promoter
- David I. KellyDirector
- Paul R. EdickDirector
- Offering amount
- $47.6M
- Amount sold
- $47.6M
- First sale
- Nov 2015
- Incorporated
- Other, Ireland, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapSimply Wall St31 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
Robinhood29 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Public26 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
StockTwits25 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Seeking Alpha25 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Iterum Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Iterum Therapeutics do?
- Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens. The company's lead product, sulopenem (ORLYNVAH), has been approved by the FDA for treating uncomplicated urinary tract infections in adult women.
- Who founded Iterum Therapeutics?
- Iterum Therapeutics was founded by Michael W. Dunne, Corey N. Fishman in 2015.
- Who are Iterum Therapeutics's investors?
- Iterum Therapeutics's investors include Bay City Capital, Canaan Partners, Sofinnova Ventures, Frazier Life Sciences, Sofinnova Venture Partners.
- How much funding has Iterum Therapeutics raised?
- Iterum Therapeutics has disclosed $131.4M raised across 4 rounds.
- Where is Iterum Therapeutics headquartered?
- Iterum Therapeutics is headquartered in Dublin, US.